首页 > 最新文献

Journal of Cardiac Surgery最新文献

英文 中文
Systematic Review and Meta-Analysis of Comparative Studies: Transcatheter Versus Surgical Closure for Postinfarct Ventricular Septal Defect 比较研究的系统回顾和元分析:经导管与手术闭合治疗梗死后室间隔缺损
IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-30 DOI: 10.1155/2024/8159580
Akira Yamaguchi, Junichi Shimamura, Shinichi Fukuhara, Hiroki Ueyama, Hisato Takagi, Toshiki Kuno

Background: Postinfarct ventricular septal defect (PIVSD) is a serious complication of acute myocardial infarction (AMI). Transcatheter closure is a potential alternative to surgical closure for PIVSD patients.

Objective: This meta-analysis compares the clinical outcomes of transcatheter closure versus surgical closure for PIVSD.

Methods: A systemic search of PubMed and Embase until January 2023 identified studies comparing transcatheter versus surgical PIVSD closure. Primary outcomes included short-term mortality. Short-term mortality referred to the number of in-hospital or 30-day deaths. Secondary outcomes comprised residual shunt/reintervention incidence, difference in time from AMI or PIVSD diagnosis to intervention, the presence of cardiogenic shock, incidence of perioperative mechanical support, PIVSD size difference, and overall mortality at follow-up.

Results: Seven studies comprising 603 patients were included. Short-term mortality (OR, 1.30; 95% CI [0.90, 1.89]; p = 0.17; I2  = 3.0%) did not significantly differ between the two groups. The incidence of residual shunt/reintervention (OR, 3.56; CI, 1.33–9.59; p = 0.01; I2  = 63.0%) and PIVSD size (mean difference, −3.94 mm; CI [−6.90, −0.99]; p = 0.09; I2  = 83.0%) were significantly different; however, the other secondary outcomes were not significantly different.

Conclusion: Transcatheter and surgical closure demonstrate similar short-term mortality. Despite a higher incidence of residual shunt or reintervention in transcatheter closure, it may be a viable option in patients with small size of PIVSD.

背景:梗死后室间隔缺损(PIVSD)是急性心肌梗死(AMI)的一种严重并发症。对于 PIVSD 患者来说,经导管封堵术是手术封堵的潜在替代方案。 目的:本荟萃分析比较了经导管封堵与手术封堵治疗 PIVSD 的临床效果。 方法:在PubMed上进行系统检索:对PubMed和Embase进行系统检索,直至2023年1月,发现了比较经导管与手术PIVSD闭合的研究。主要结果包括短期死亡率。短期死亡率是指住院或30天内死亡的人数。次要结果包括残余分流/再干预发生率、从AMI或PIVSD诊断到干预的时间差、心源性休克的存在、围术期机械支持的发生率、PIVSD大小差异以及随访时的总死亡率。 结果:共纳入了七项研究,包括 603 名患者。两组患者的短期死亡率(OR,1.30;95% CI [0.90,1.89];P = 0.17;I2 = 3.0%)无显著差异。残余分流/再介入的发生率(OR,3.56;CI,1.33-9.59;P = 0.01;I2 = 63.0%)和 PIVSD 大小(平均差异,-3.94 mm;CI [-6.90,-0.99];P = 0.09;I2 = 83.0%)有显著差异;但其他次要结果无显著差异。 结论经导管封堵术和手术封堵术的短期死亡率相似。尽管经导管闭合术中残留分流或再次介入的发生率较高,但对于PIVSD较小的患者来说,经导管闭合术可能是一种可行的选择。
{"title":"Systematic Review and Meta-Analysis of Comparative Studies: Transcatheter Versus Surgical Closure for Postinfarct Ventricular Septal Defect","authors":"Akira Yamaguchi,&nbsp;Junichi Shimamura,&nbsp;Shinichi Fukuhara,&nbsp;Hiroki Ueyama,&nbsp;Hisato Takagi,&nbsp;Toshiki Kuno","doi":"10.1155/2024/8159580","DOIUrl":"https://doi.org/10.1155/2024/8159580","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> Postinfarct ventricular septal defect (PIVSD) is a serious complication of acute myocardial infarction (AMI). Transcatheter closure is a potential alternative to surgical closure for PIVSD patients.</p>\u0000 <p><b>Objective:</b> This meta-analysis compares the clinical outcomes of transcatheter closure versus surgical closure for PIVSD.</p>\u0000 <p><b>Methods:</b> A systemic search of PubMed and Embase until January 2023 identified studies comparing transcatheter versus surgical PIVSD closure. Primary outcomes included short-term mortality. Short-term mortality referred to the number of in-hospital or 30-day deaths. Secondary outcomes comprised residual shunt/reintervention incidence, difference in time from AMI or PIVSD diagnosis to intervention, the presence of cardiogenic shock, incidence of perioperative mechanical support, PIVSD size difference, and overall mortality at follow-up.</p>\u0000 <p><b>Results:</b> Seven studies comprising 603 patients were included. Short-term mortality (OR, 1.30; 95% CI [0.90, 1.89]; <i>p</i> = 0.17; <i>I</i><sup>2</sup> <i> = </i>3.0%) did not significantly differ between the two groups. The incidence of residual shunt/reintervention (OR, 3.56; CI, 1.33–9.59; <i>p</i> = 0.01; <i>I</i><sup>2</sup> <i> = </i>63.0%) and PIVSD size (mean difference, −3.94 mm; CI [−6.90, −0.99]; <i>p</i> = 0.09; <i>I</i><sup>2</sup> <i> = </i>83.0%) were significantly different; however, the other secondary outcomes were not significantly different.</p>\u0000 <p><b>Conclusion:</b> Transcatheter and surgical closure demonstrate similar short-term mortality. Despite a higher incidence of residual shunt or reintervention in transcatheter closure, it may be a viable option in patients with small size of PIVSD.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/8159580","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142541011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertrophic Cardiomyopathy With Elongated Mitral Valve Leaflets: Clinical Characteristics and Surgical Results 肥厚型心肌病伴二尖瓣瓣叶延长:临床特征和手术结果
IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-29 DOI: 10.1155/2024/7078246
Xianying Liu, Daniel McGrath, Kelly Ohlrich, Frederick Y. Chen, Lawrence S. Lee, Michael Robich

Background: Hypertrophic cardiomyopathy (HCM) is commonly associated with mitral valve pathology. A large majority of patients with HCM have elongated anterior and posterior mitral leaflets. There remains debate regarding the necessity and role of concomitant mitral valve surgery at the time of septal myectomy. We aimed to describe the characteristics and share our surgical experiences with this specific group of patients.

Methods: This retrospective single-center study investigates adult patients with HCM, with or without elongated mitral valve leaflets (MVLs), who underwent elective septal myectomy with or without concomitant mitral valve intervention, between January 1, 2016, and June 30, 2020. Clinical data were obtained from institutional medical records as well as the Society of Thoracic Surgeons data registry. The clinical characteristics and in-hospital surgical outcomes were compared between patients with an elongated MVL and those without.

Results: In total, 379 patients underwent septal myectomy, and 22 patients with intrinsic mitral valve disease were excluded. In addition, 23 patients were excluded due to missing data. Of the remaining 334 patients, 131 (39.2%) had elongated MVL and concomitant MVL plication. Patients with elongated MVL had higher rates of preoperative mitral valve systolic anterior motion (SAM) (94.7% vs. 86.7%, p = 0.019) and higher preoperative provoked left ventricular outflow tract gradient (LVOTG) (134.5 mmHg versus 125.3 mmHg, p = 0.046). Post septal myectomy and mitral valve plication, they had lower rates of postoperative residual mitral regurgitation (3.8% vs. 12.8%, p = 0.006), comparable rates of residual SAM (28.2% vs. 31.5%, p = 0.524), postoperative provoked LVOTG (15.4 mmHg vs. 14.0 mmHg, p = 0.317), 30-day major adverse cardiopulmonary events (2.3% vs. 3.9%, p = 0.409), and mortality (0% vs. 1.0%, p = 0.255).

Conclusions: Elongated MVLs contribute more significantly to dynamic LVOT obstruction, as evidenced during provocative testing. Concomitant mitral valve intervention during septal myectomy can be performed safely and may provide an effective strategy to resolve SAM and stress-induced LVOTG.

背景:肥厚型心肌病(HCM)通常与二尖瓣病变有关。大多数 HCM 患者的二尖瓣前叶和后叶都被拉长。关于在进行室间隔瓣膜切除术的同时进行二尖瓣手术的必要性和作用仍存在争议。我们旨在描述这类特殊患者的特征并分享我们的手术经验。 方法:这项回顾性单中心研究调查了在 2016 年 1 月 1 日至 2020 年 6 月 30 日期间接受或不接受二尖瓣介入治疗的选择性室间隔缺损切除术的成年 HCM 患者,无论患者是否伴有二尖瓣叶变长(MVL)。临床数据来自医疗机构的病历以及胸外科医师协会的数据登记。比较了MVL拉长患者和未拉长患者的临床特征和院内手术结果。 结果:共有 379 名患者接受了室间隔肌层切除术,其中有 22 名患有二尖瓣固有疾病的患者被排除在外。此外,23 名患者因数据缺失而被排除。在剩余的 334 例患者中,131 例(39.2%)患者的 MVL 被拉长,并同时进行了 MVL 植入术。MVL 拉长的患者术前二尖瓣收缩前运动(SAM)率较高(94.7% 对 86.7%,P = 0.019),术前诱发的左室流出道梯度(LVOTG)较高(134.5 mmHg 对 125.3 mmHg,P = 0.046)。室间隔肌肉切除术和二尖瓣成形术后,他们术后残余二尖瓣反流的比例较低(3.8% 对 12.8%,P = 0.006),残余 SAM 的比例相当(28.2% 对 31.5%,P = 0.524)。5%,p = 0.524)、术后诱发 LVOTG(15.4 mmHg vs. 14.0 mmHg,p = 0.317)、30 天主要不良心肺事件(2.3% vs. 3.9%,p = 0.409)和死亡率(0% vs. 1.0%,p = 0.255)相当。 结论激振试验证明,拉长的 MVL 对动态左心室出口梗阻的影响更大。在进行室间隔肌肉切除术时,可以安全地同时进行二尖瓣介入治疗,这可能是解决 SAM 和压力诱发的 LVOTG 的有效策略。
{"title":"Hypertrophic Cardiomyopathy With Elongated Mitral Valve Leaflets: Clinical Characteristics and Surgical Results","authors":"Xianying Liu,&nbsp;Daniel McGrath,&nbsp;Kelly Ohlrich,&nbsp;Frederick Y. Chen,&nbsp;Lawrence S. Lee,&nbsp;Michael Robich","doi":"10.1155/2024/7078246","DOIUrl":"https://doi.org/10.1155/2024/7078246","url":null,"abstract":"<div>\u0000 <p><b>Background:</b> Hypertrophic cardiomyopathy (HCM) is commonly associated with mitral valve pathology. A large majority of patients with HCM have elongated anterior and posterior mitral leaflets. There remains debate regarding the necessity and role of concomitant mitral valve surgery at the time of septal myectomy. We aimed to describe the characteristics and share our surgical experiences with this specific group of patients.</p>\u0000 <p><b>Methods:</b> This retrospective single-center study investigates adult patients with HCM, with or without elongated mitral valve leaflets (MVLs), who underwent elective septal myectomy with or without concomitant mitral valve intervention, between January 1, 2016, and June 30, 2020. Clinical data were obtained from institutional medical records as well as the Society of Thoracic Surgeons data registry. The clinical characteristics and in-hospital surgical outcomes were compared between patients with an elongated MVL and those without.</p>\u0000 <p><b>Results:</b> In total, 379 patients underwent septal myectomy, and 22 patients with intrinsic mitral valve disease were excluded. In addition, 23 patients were excluded due to missing data. Of the remaining 334 patients, 131 (39.2%) had elongated MVL and concomitant MVL plication. Patients with elongated MVL had higher rates of preoperative mitral valve systolic anterior motion (SAM) (94.7% vs. 86.7%, <i>p</i> = 0.019) and higher preoperative provoked left ventricular outflow tract gradient (LVOTG) (134.5 mmHg versus 125.3 mmHg, <i>p</i> = 0.046). Post septal myectomy and mitral valve plication, they had lower rates of postoperative residual mitral regurgitation (3.8% vs. 12.8%, <i>p</i> = 0.006), comparable rates of residual SAM (28.2% vs. 31.5%, <i>p</i> = 0.524), postoperative provoked LVOTG (15.4 mmHg vs. 14.0 mmHg, <i>p</i> = 0.317), 30-day major adverse cardiopulmonary events (2.3% vs. 3.9%, <i>p</i> = 0.409), and mortality (0% vs. 1.0%, <i>p</i> = 0.255).</p>\u0000 <p><b>Conclusions:</b> Elongated MVLs contribute more significantly to dynamic LVOT obstruction, as evidenced during provocative testing. Concomitant mitral valve intervention during septal myectomy can be performed safely and may provide an effective strategy to resolve SAM and stress-induced LVOTG.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/7078246","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142540825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes Mellitus Predicts Severe Respiratory Failure After Aortic Arch Replacement 糖尿病可预测主动脉弓置换术后的严重呼吸衰竭
IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-22 DOI: 10.1155/2024/3776969
Ivancarmine Gambardella, Berhane Worku, Christopher Lau, Robert Tranbaugh, Sandhya Balaram, Leonard Girardi

Objective: The lung is a target organ of diabetes mellitus (DM) via glycation of pulmonary elastin and collagen. In addition, hyperglycemia facilitates hypercapnic respiratory failure, which is instead mitigated by low-carbohydrate high-lipid (LC-HL) nutrition. We sought to determine the association between diabetes and severe respiratory failure (SRF, i.e., need of reintubationtracheostomy) after open aortic arch replacement (AAR).

Methods: Machine learning algorithms were evaluated for precision and recall (F2 score) and for clinical applicability to predict SRF. Conditional regression evaluated independent predictors of SRF after 1:2 propensity-score matching.

Results: Information on diabetic status was available in 1275 patients undergoing AAR (1997–2023). Although support vector machine presented the highest F2 score (F2 = 0.337), conditional inference trees provided the most clinically applicable algorithm: diabetes was the best predictor of SRF, which occurred in 20/150 diabetics (13.3%) vs. 40/1125 nondiabetics (3.6%) (p < 0.01). In diabetics, left ventricular ejection fraction (LVEF) was the next best predictor of SRF, which occurred in 8/20 diabetics with LVEF ≤ 30% (40%) vs. 12/130 diabetics with LVEF >30% (9.2%) (p = 0.02). In nondiabetics, chronic obstructive pulmonary disease (COPD) was the next best predictor of respiratory failure, which occurred in 14/177 nondiabetics with COPD (7.9%) vs. 26/948 nondiabetics without COPD (2.7%) (p = 0.01). In the matched sample, diabetes was independently able to predict SRF (OR 2.20, 95% CI 1.10 | 4.42).

Conclusions: DM was the best predictor of SRF after AAR. Strict glycemic control and LC-HL nutrition should be evaluated as measures to reduce postoperative SRF in diabetic patients.

目的:肺是糖尿病(DM)通过肺弹性蛋白和胶原蛋白糖化作用的靶器官。此外,高血糖会导致高碳酸血症性呼吸衰竭,而低碳水化合物高脂(LC-HL)营养可减轻这种情况。我们试图确定糖尿病与开腹主动脉弓置换术(AAR)后严重呼吸衰竭(SRF,即需要再次插管/气管造口术)之间的关系。 方法:评估机器学习算法预测SRF的精确度和召回率(F2得分)以及临床适用性。条件回归评估了 1:2 倾向分数匹配后 SRF 的独立预测因素。 结果1275名接受AAR治疗的患者(1997-2023年)的糖尿病状态信息可用。虽然支持向量机的 F2 得分最高(F2 = 0.337),但条件推理树提供了最适用于临床的算法:糖尿病是 SRF 的最佳预测因素,20/150 例糖尿病患者(13.3%)与 40/1125 例非糖尿病患者(3.6%)中都出现了 SRF(p <0.01)。在糖尿病患者中,左心室射血分数(LVEF)是 SRF 的次佳预测指标,LVEF ≤ 30% 的糖尿病患者有 8/20 例(40%),而 LVEF ≥gt;30% 的糖尿病患者有 12/130 例(9.2%)(P = 0.02)。在非糖尿病患者中,慢性阻塞性肺病(COPD)是预测呼吸衰竭的次佳指标,有 COPD 的非糖尿病患者有 14/177 例(7.9%),无 COPD 的非糖尿病患者有 26/948 例(2.7%)(P = 0.01)。在匹配样本中,糖尿病可独立预测 SRF(OR 2.20,95% CI 1.10 | 4.42)。 结论:糖尿病是 SRF 的最佳预测因素:糖尿病是 AAR 后 SRF 的最佳预测因素。应将严格控制血糖和低密度脂蛋白-高密度脂蛋白营养作为减少糖尿病患者术后 SRF 的措施进行评估。
{"title":"Diabetes Mellitus Predicts Severe Respiratory Failure After Aortic Arch Replacement","authors":"Ivancarmine Gambardella,&nbsp;Berhane Worku,&nbsp;Christopher Lau,&nbsp;Robert Tranbaugh,&nbsp;Sandhya Balaram,&nbsp;Leonard Girardi","doi":"10.1155/2024/3776969","DOIUrl":"https://doi.org/10.1155/2024/3776969","url":null,"abstract":"<div>\u0000 <p><b>Objective:</b> The lung is a target organ of diabetes mellitus (DM) via glycation of pulmonary elastin and collagen. In addition, hyperglycemia facilitates hypercapnic respiratory failure, which is instead mitigated by low-carbohydrate high-lipid (LC-HL) nutrition. We sought to determine the association between diabetes and severe respiratory failure (SRF, i.e., need of reintubationtracheostomy) after open aortic arch replacement (AAR).</p>\u0000 <p><b>Methods:</b> Machine learning algorithms were evaluated for precision and recall (F2 score) and for clinical applicability to predict SRF. Conditional regression evaluated independent predictors of SRF after 1:2 propensity-score matching.</p>\u0000 <p><b>Results:</b> Information on diabetic status was available in 1275 patients undergoing AAR (1997–2023). Although support vector machine presented the highest F2 score (<i>F</i>2 = 0.337), conditional inference trees provided the most clinically applicable algorithm: diabetes was the best predictor of SRF, which occurred in 20/150 diabetics (13.3%) vs. 40/1125 nondiabetics (3.6%) (<i>p</i> &lt; 0.01). In diabetics, left ventricular ejection fraction (LVEF) was the next best predictor of SRF, which occurred in 8/20 diabetics with LVEF ≤ 30% (40%) vs. 12/130 diabetics with LVEF &gt;30% (9.2%) (<i>p</i> = 0.02). In nondiabetics, chronic obstructive pulmonary disease (COPD) was the next best predictor of respiratory failure, which occurred in 14/177 nondiabetics with COPD (7.9%) vs. 26/948 nondiabetics without COPD (2.7%) (<i>p</i> = 0.01). In the matched sample, diabetes was independently able to predict SRF (OR 2.20, 95% CI 1.10 | 4.42).</p>\u0000 <p><b>Conclusions:</b> DM was the best predictor of SRF after AAR. Strict glycemic control and LC-HL nutrition should be evaluated as measures to reduce postoperative SRF in diabetic patients.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/3776969","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142524916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac Metabolic Stress During Ischemia and Reperfusion in Patients Undergoing Coronary Artery Bypass Surgery Using Either Calafiore or Modified Del Nido Cardioplegic Solutions 使用卡拉菲奥雷或改良德尔尼多心脏麻痹溶液进行冠状动脉搭桥手术的患者在缺血和再灌注期间的心脏代谢压力
IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-16 DOI: 10.1155/2024/5562548
Abd Alhade Massa, Ahmad Walid Izzat, Rakan Saadoun, Mohammad Bashar Izzat

Objective: Calafiore and modified del Nido cardioplegic solutions are currently being used during coronary artery bypass surgery. This study aims to compare myocardial ischemic stress associated with both solutions by studying the changes in cardiac metabolites during cardioplegic ischemic arrest and early reperfusion.

Methods: Biopsy specimens were taken from the left ventricles of 20 patients undergoing routine coronary artery bypass grafting using Calafiore or modified del Nido cardioplegic solutions. Biopsies were taken immediately after the beginning of extracorporeal circulation (basal biopsy), 30 min after application of the aortic cross-clamp (ischemic biopsy), and 20 min following the removal of aortic cross-clamp (reperfusion biopsy) and were analyzed for their amino acid and lactic acid contents using amino acid analyzer and appropriate kits. Peripheral blood samples were also collected for the determination of blood concentrations of cardiac proteins (CK-MB and troponin I) using an immunofluorescence scanner.

Results: Both CK-MB and troponin I increased significantly 12 h postoperatively and were associated with an increase in myocardial lactic acid, but there were no significant differences in markers of myocardial injury between the two groups. Comparison of amino acid concentrations between the two groups according to sampling time showed that glutamic acid concentrations were significantly lower in the Calafiore cardioplegia group compared to the del Nido cardioplegia group, but there were no other significant differences in markers of metabolic stress (taurine and alanine/glutamate ratio) between the two groups. Moreover, there were no significant differences in changes in amino acid concentrations regardless of the type of cardioplegic solution used.

Conclusions: Cardioplegic ischemic arrest and early reperfusion are associated with a rise in myocardial metabolic stress. Both Calafiore and modified del Nido cardioplegic solutions are effective in attenuating myocardial substrate derangements and confer equal myocardial protection during routine coronary artery bypass surgery.

Trial Registration: ClinicalTrials.gov identifier: NCT06287372

目的:目前在冠状动脉搭桥手术中使用卡拉菲奥雷和改良德尔尼多心脏麻痹溶液。本研究旨在通过研究心脏麻痹缺血停止和早期再灌注过程中心脏代谢物的变化,比较两种溶液对心肌造成的缺血压力。 研究方法活检标本取自 20 名接受常规冠状动脉旁路移植术的患者的左心室,使用的是卡拉菲奥雷或改良德尔尼多心脏麻痹溶液。活组织样本分别在体外循环开始后立即提取(基础活组织样本)、使用主动脉交叉夹钳 30 分钟后提取(缺血活组织样本)和去除主动脉交叉夹钳 20 分钟后提取(再灌注活组织样本),并使用氨基酸分析仪和适当的试剂盒分析其氨基酸和乳酸含量。此外,还采集了外周血样本,使用免疫荧光扫描仪测定血液中心脏蛋白(CK-MB 和肌钙蛋白 I)的浓度。 结果术后 12 小时,CK-MB 和肌钙蛋白 I 均明显增加,且与心肌乳酸的增加有关,但两组心肌损伤指标无明显差异。根据取样时间比较两组的氨基酸浓度发现,卡拉菲奥雷心脏麻痹组的谷氨酸浓度明显低于德尔尼多心脏麻痹组,但两组在代谢压力指标(牛磺酸和丙氨酸/谷氨酸比率)方面没有其他显著差异。此外,无论使用哪种心脏麻痹溶液,氨基酸浓度的变化均无明显差异。 结论心肌缺血停搏和早期再灌注与心肌代谢应激的增加有关。在常规冠状动脉搭桥手术中,Calafiore 和改良 del Nido 两种心脏麻痹溶液都能有效减轻心肌底物紊乱,并提供同等的心肌保护。 试验注册:临床试验注册:ClinicalTrials.gov identifier:NCT06287372
{"title":"Cardiac Metabolic Stress During Ischemia and Reperfusion in Patients Undergoing Coronary Artery Bypass Surgery Using Either Calafiore or Modified Del Nido Cardioplegic Solutions","authors":"Abd Alhade Massa,&nbsp;Ahmad Walid Izzat,&nbsp;Rakan Saadoun,&nbsp;Mohammad Bashar Izzat","doi":"10.1155/2024/5562548","DOIUrl":"https://doi.org/10.1155/2024/5562548","url":null,"abstract":"<div>\u0000 <p><b>Objective:</b> Calafiore and modified del Nido cardioplegic solutions are currently being used during coronary artery bypass surgery. This study aims to compare myocardial ischemic stress associated with both solutions by studying the changes in cardiac metabolites during cardioplegic ischemic arrest and early reperfusion.</p>\u0000 <p><b>Methods:</b> Biopsy specimens were taken from the left ventricles of 20 patients undergoing routine coronary artery bypass grafting using Calafiore or modified del Nido cardioplegic solutions. Biopsies were taken immediately after the beginning of extracorporeal circulation (basal biopsy), 30 min after application of the aortic cross-clamp (ischemic biopsy), and 20 min following the removal of aortic cross-clamp (reperfusion biopsy) and were analyzed for their amino acid and lactic acid contents using amino acid analyzer and appropriate kits. Peripheral blood samples were also collected for the determination of blood concentrations of cardiac proteins (CK-MB and troponin I) using an immunofluorescence scanner.</p>\u0000 <p><b>Results:</b> Both CK-MB and troponin I increased significantly 12 h postoperatively and were associated with an increase in myocardial lactic acid, but there were no significant differences in markers of myocardial injury between the two groups. Comparison of amino acid concentrations between the two groups according to sampling time showed that glutamic acid concentrations were significantly lower in the Calafiore cardioplegia group compared to the del Nido cardioplegia group, but there were no other significant differences in markers of metabolic stress (taurine and alanine/glutamate ratio) between the two groups. Moreover, there were no significant differences in changes in amino acid concentrations regardless of the type of cardioplegic solution used.</p>\u0000 <p><b>Conclusions:</b> Cardioplegic ischemic arrest and early reperfusion are associated with a rise in myocardial metabolic stress. Both Calafiore and modified del Nido cardioplegic solutions are effective in attenuating myocardial substrate derangements and confer equal myocardial protection during routine coronary artery bypass surgery.</p>\u0000 <p><b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT06287372</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/5562548","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142443566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-Center Success of Concomitant Cryothermal Cox-Maze IV Procedure 单中心成功实施低温 Cox-Maze IV 程序
IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-06 DOI: 10.1155/2024/1136595
Benedikt Mayr, Anna Maria Kokott, Teodora Georgescu, Bernhard Voss, Markus Krane, Keti Vitanova

Background. Despite the guideline recommendation, implementation of the Cox-maze (CM) IV procedure has been variable and current data are limited. Methods. We reviewed patients with concomitant CM IV procedure (05/2019−05/2020). The primary endpoints of the study were the success rate of surgical ablation and continuity of sinus rhythm (SR) 1 year after surgery. Secondary endpoints included permanent pacemaker (PPM) implantation, postoperative mortality, and identification of predictors for postoperative SR. Results. The concomitant CM IV procedure was performed in 92 patients. Indications were persistent atrial fibrillation (AF) in 40 patients (43.5%), paroxysmal AF in 36 (39.1%), and long-standing persistent AF in 16 (17.4%). At hospital discharge, SR was achieved in 49 patients (63.6%) and PPM implantation was necessary in 12 patients (13%). At 1 year after surgical ablation, SR was seen in 31 patients (59.6%) and PPM implantation was required in six further patients (6.5%). Patients with long-standing persistent AF were significantly less likely to achieve SR (odds ratio (OR): 0.18, p = 0.003), and postoperative mortality was significantly increased in this subgroup (hazard ratio (HR): 5.4, p = 0.02). In patients with enlarged left atrial (LA) diameter, the probability of achieving SR was significantly decreased (OR: 0.48, p = 0.045). Need for postoperative dialysis (HR: 12.9, p = 0.02) and prolonged stay in the intensive care unit (HR: 2.2, p = 0.01) were independently associated with increased mortality after CM IV. Conclusions. The cryothermal CM IV procedure has an overall 1-year success rate of 60% with increased rates of PPM implantation. Patients with long-standing persistent AF and increased LA diameter were significantly less likely to achieve SR.

背景。尽管有指南建议,Cox-maze(CM)IV 程序的实施情况却不尽相同,目前的数据也很有限。方法。我们回顾了同时进行CM IV手术的患者(2019年5月至2020年5月)。研究的主要终点是手术消融的成功率和术后一年窦性心律(SR)的持续性。次要终点包括永久起搏器(PPM)植入、术后死亡率以及术后窦性心律预测因素的鉴定。结果。92名患者同时进行了CM IV手术。40名患者(43.5%)的适应症为持续性房颤(AF),36名患者(39.1%)为阵发性房颤,16名患者(17.4%)为长期持续性房颤。出院时,49 名患者(63.6%)达到了 SR,12 名患者(13%)需要植入 PPM。手术消融 1 年后,31 名患者(59.6%)达到了 SR,另有 6 名患者(6.5%)需要植入 PPM。长期持续性房颤患者获得 SR 的几率明显较低(几率比 (OR):0.18,P = 0.003),而且该亚组患者的术后死亡率明显增加(危险比 (HR):5.4,P = 0.02)。在左心房(LA)直径增大的患者中,达到 SR 的概率明显降低(OR:0.48,p = 0.045)。术后需要透析(HR:12.9,p = 0.02)和在重症监护室住院时间延长(HR:2.2,p = 0.01)与 CM IV 后死亡率增加有独立关联。结论低温 CM IV 手术的 1 年总体成功率为 60%,PPM 植入率有所提高。长期持续房颤和 LA 直径增大的患者获得 SR 的可能性明显降低。
{"title":"Single-Center Success of Concomitant Cryothermal Cox-Maze IV Procedure","authors":"Benedikt Mayr,&nbsp;Anna Maria Kokott,&nbsp;Teodora Georgescu,&nbsp;Bernhard Voss,&nbsp;Markus Krane,&nbsp;Keti Vitanova","doi":"10.1155/2024/1136595","DOIUrl":"https://doi.org/10.1155/2024/1136595","url":null,"abstract":"<div>\u0000 <p><i>Background</i>. Despite the guideline recommendation, implementation of the Cox-maze (CM) IV procedure has been variable and current data are limited. <i>Methods</i>. We reviewed patients with concomitant CM IV procedure (05/2019−05/2020). The primary endpoints of the study were the success rate of surgical ablation and continuity of sinus rhythm (SR) 1 year after surgery. Secondary endpoints included permanent pacemaker (PPM) implantation, postoperative mortality, and identification of predictors for postoperative SR. <i>Results</i>. The concomitant CM IV procedure was performed in 92 patients. Indications were persistent atrial fibrillation (AF) in 40 patients (43.5%), paroxysmal AF in 36 (39.1%), and long-standing persistent AF in 16 (17.4%). At hospital discharge, SR was achieved in 49 patients (63.6%) and PPM implantation was necessary in 12 patients (13%). At 1 year after surgical ablation, SR was seen in 31 patients (59.6%) and PPM implantation was required in six further patients (6.5%). Patients with long-standing persistent AF were significantly less likely to achieve SR (odds ratio (OR): 0.18, <i>p</i> = 0.003), and postoperative mortality was significantly increased in this subgroup (hazard ratio (HR): 5.4, <i>p</i> = 0.02). In patients with enlarged left atrial (LA) diameter, the probability of achieving SR was significantly decreased (OR: 0.48, <i>p</i> = 0.045). Need for postoperative dialysis (HR: 12.9, <i>p</i> = 0.02) and prolonged stay in the intensive care unit (HR: 2.2, <i>p</i> = 0.01) were independently associated with increased mortality after CM IV. <i>Conclusions</i>. The cryothermal CM IV procedure has an overall 1-year success rate of 60% with increased rates of PPM implantation. Patients with long-standing persistent AF and increased LA diameter were significantly less likely to achieve SR.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/1136595","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142152265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interrupted Aortic Arch: Assessment of Morphology and Associated Cardiovascular Anomalies on Computed Tomography Angiography 主动脉弓中断:计算机断层扫描血管造影术对形态学和相关心血管异常的评估
IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-05 DOI: 10.1155/2024/5552627
Vidiyala Pujitha, Niraj Nirmal Pandey, Mansi Verma, Sanjeev Kumar, Sivasubramanian Ramakrishnan, Priya Jagia

Aim. The present study sought to evaluate the cardiovascular morphology and associated anomalies in patients with interrupted aortic arch (IAA) on CT angiography. Materials and Methods. A retrospective review of our departmental database was conducted to identify patients diagnosed with IAA on CT angiography between January 2014 and September 2022. The demographic information, anatomic characteristics, and associated cardiovascular abnormalities in patients with IAA were assessed. The morphological types of IAA were described in accordance with Celoria–Patton classification. Results. IAA was seen in 49 patients (32 males and 17 females; mean age: 15.9 months). The most common type of IAA based on the site of interruption was type A seen in 27/49 (55.1%) patients, while type B was observed in 22/49 (44.9%) patients. No patient of type C IAA was encountered in the current series. The most commonly associated cardiovascular anomaly was patent ductus arteriosus (PDA) seen in 45/49 (91.8%) patients. Atrial septal defect was seen in 15/49 (30.6%) patients, while 39/49 (79.6%) patients had a ventricular septal defect (VSD). Common arterial trunk was the most common abnormal ventriculo-arterial connection seen in 13/49 (26.5%) patients. Aorto-pulmonary window was associated with 7/49 (14.3%) patients. Conclusion. IAA is a rare congenital heart defect associated with an array of cardiovascular anomalies, most common being PDA and VSD. CT angiography is useful not only in diagnosing and characterizing the IAA but also in identifying associated anomalies which may have a bearing on the clinical presentation, prognosis, and surgical management.

研究目的本研究旨在通过 CT 血管造影评估主动脉弓中断(IAA)患者的心血管形态和相关异常。材料和方法。我们对科室数据库进行了回顾性审查,以确定在 2014 年 1 月至 2022 年 9 月期间通过 CT 血管造影确诊为 IAA 的患者。评估IAA患者的人口统计学信息、解剖学特征和相关心血管异常。根据 Celoria-Patton 分类法描述了 IAA 的形态学类型。结果。49名患者(32名男性,17名女性;平均年龄:15.9个月)患有IAA。根据中断部位,最常见的 IAA 类型是 A 型,见于 27/49 例患者(55.1%),而 B 型见于 22/49 例患者(44.9%)。本系列中没有发现 C 型 IAA 患者。最常见的心血管异常是动脉导管未闭(PDA),见于 45/49 例(91.8%)患者。15/49(30.6%)例患者出现房间隔缺损,39/49(79.6%)例患者出现室间隔缺损(VSD)。动脉总干是最常见的异常心室-动脉连接,见于 13/49 (26.5%)例患者。7/49(14.3%)例患者伴有主动脉-肺窗。结论IAA是一种罕见的先天性心脏缺陷,伴有一系列心血管畸形,最常见的是PDA和VSD。CT 血管造影不仅有助于诊断 IAA 和确定其特征,还能发现与之相关的异常,这些异常可能会对临床表现、预后和手术治疗产生影响。
{"title":"Interrupted Aortic Arch: Assessment of Morphology and Associated Cardiovascular Anomalies on Computed Tomography Angiography","authors":"Vidiyala Pujitha,&nbsp;Niraj Nirmal Pandey,&nbsp;Mansi Verma,&nbsp;Sanjeev Kumar,&nbsp;Sivasubramanian Ramakrishnan,&nbsp;Priya Jagia","doi":"10.1155/2024/5552627","DOIUrl":"https://doi.org/10.1155/2024/5552627","url":null,"abstract":"<div>\u0000 <p><i>Aim</i>. The present study sought to evaluate the cardiovascular morphology and associated anomalies in patients with interrupted aortic arch (IAA) on CT angiography. <i>Materials and Methods</i>. A retrospective review of our departmental database was conducted to identify patients diagnosed with IAA on CT angiography between January 2014 and September 2022. The demographic information, anatomic characteristics, and associated cardiovascular abnormalities in patients with IAA were assessed. The morphological types of IAA were described in accordance with Celoria–Patton classification. <i>Results</i>. IAA was seen in 49 patients (32 males and 17 females; mean age: 15.9 months). The most common type of IAA based on the site of interruption was type A seen in 27/49 (55.1%) patients, while type B was observed in 22/49 (44.9%) patients. No patient of type C IAA was encountered in the current series. The most commonly associated cardiovascular anomaly was patent ductus arteriosus (PDA) seen in 45/49 (91.8%) patients. Atrial septal defect was seen in 15/49 (30.6%) patients, while 39/49 (79.6%) patients had a ventricular septal defect (VSD). Common arterial trunk was the most common abnormal ventriculo-arterial connection seen in 13/49 (26.5%) patients. Aorto-pulmonary window was associated with 7/49 (14.3%) patients. <i>Conclusion</i>. IAA is a rare congenital heart defect associated with an array of cardiovascular anomalies, most common being PDA and VSD. CT angiography is useful not only in diagnosing and characterizing the IAA but also in identifying associated anomalies which may have a bearing on the clinical presentation, prognosis, and surgical management.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/5552627","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142152343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of Robotic Coronary Surgery after Established Mitral Robotic Program 在建立二尖瓣机器人项目后实施机器人冠状动脉手术
IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-12 DOI: 10.1155/2024/8822068
Valentina Grazioli, Matteo Pettinari, Davide Personeni, Ascanio Graniero, Laura Giroletti, Giovanni Albano, Matteo Parrinello, Claudio Roscitano, Gianluca Torregrossa, Alfonso Agnino

Aims. We described our advancement in the field of robotic cardiac surgery, particularly in the context of coronary revascularization. We will outline how the application of the Da Vinci® X Surgical System in coronary surgery is safe, feasible, and reproducible after an adequate familiarization with the docking system, that could come from a previous mitral valve robotic program, and after a sufficient learning time period. Methods. Between February 2021 and December 2023, a cohort of 33 patients underwent coronary artery revascularization surgery, involving robotic harvesting of the left mammary artery and off-pump hand-direct bypass to the left descending coronary artery or marginal coronary artery. In cases of hybrid revascularization, percutaneous coronary intervention with drug-eluting stent placement was performed either before or after surgery. Results. There were no mortalities within 30 days and at 1 year of follow-up after surgery. Notably, 70% of patients were extubated in the operating room immediately following the surgical procedure. The median postoperative mechanical ventilation time was 0 [0–4] hours, and the median length of stay in the intensive care unit was 21 [20–48] hours. A progressive reduction of the console and instrumental Da Vinci® X Surgical System was underling after the 21st patient. Conclusion. The promising outcomes observed in this series highlight that robotic-assisted coronary artery bypass represents a well-established technique that could be reproducible, especially when integrated into a hybrid strategy. Initiating a program in robotic-assisted coronary artery bypass surgery can be effectively attained in particularly when a well-established background in Da Vinci® X Surgical System utilization is achieved.

目的我们介绍了机器人心脏手术领域的进展,特别是在冠状动脉血运重建方面。我们将概述达芬奇® X 手术系统在冠状动脉手术中的应用是如何在充分熟悉对接系统(可能来自于之前的二尖瓣机器人手术项目)和经过足够的学习时间后变得安全、可行和可重现的。方法。在2021年2月至2023年12月期间,33名患者接受了冠状动脉血运重建手术,包括机器人采集左乳动脉和左降支冠状动脉或边缘冠状动脉的体外手控旁路。在进行混合血管重建手术的病例中,在手术前或手术后进行了经皮冠状动脉介入治疗,并植入了药物洗脱支架。手术结果术后30天内和1年随访期间无死亡病例。值得注意的是,70%的患者在手术后立即在手术室拔管。术后机械通气的中位时间为 0 [0-4] 小时,在重症监护室的中位住院时间为 21 [20-48] 小时。在第 21 位患者之后,控制台和达芬奇® X 手术系统的器械逐渐减少。结论。本系列观察到的良好结果突出表明,机器人辅助冠状动脉搭桥术是一种成熟的技术,具有可重复性,尤其是在整合到混合策略中时。启动机器人辅助冠状动脉搭桥手术项目,尤其是在达芬奇® X 手术系统的使用方面具有成熟背景的情况下,可以有效实现。
{"title":"Implementation of Robotic Coronary Surgery after Established Mitral Robotic Program","authors":"Valentina Grazioli,&nbsp;Matteo Pettinari,&nbsp;Davide Personeni,&nbsp;Ascanio Graniero,&nbsp;Laura Giroletti,&nbsp;Giovanni Albano,&nbsp;Matteo Parrinello,&nbsp;Claudio Roscitano,&nbsp;Gianluca Torregrossa,&nbsp;Alfonso Agnino","doi":"10.1155/2024/8822068","DOIUrl":"https://doi.org/10.1155/2024/8822068","url":null,"abstract":"<div>\u0000 <p><i>Aims</i>. We described our advancement in the field of robotic cardiac surgery, particularly in the context of coronary revascularization. We will outline how the application of the Da Vinci® X Surgical System in coronary surgery is safe, feasible, and reproducible after an adequate familiarization with the docking system, that could come from a previous mitral valve robotic program, and after a sufficient learning time period. <i>Methods</i>. Between February 2021 and December 2023, a cohort of 33 patients underwent coronary artery revascularization surgery, involving robotic harvesting of the left mammary artery and off-pump hand-direct bypass to the left descending coronary artery or marginal coronary artery. In cases of hybrid revascularization, percutaneous coronary intervention with drug-eluting stent placement was performed either before or after surgery. <i>Results</i>. There were no mortalities within 30 days and at 1 year of follow-up after surgery. Notably, 70% of patients were extubated in the operating room immediately following the surgical procedure. The median postoperative mechanical ventilation time was 0 [0–4] hours, and the median length of stay in the intensive care unit was 21 [20–48] hours. A progressive reduction of the console and instrumental Da Vinci® X Surgical System was underling after the 21<sup>st</sup> patient. <i>Conclusion</i>. The promising outcomes observed in this series highlight that robotic-assisted coronary artery bypass represents a well-established technique that could be reproducible, especially when integrated into a hybrid strategy. Initiating a program in robotic-assisted coronary artery bypass surgery can be effectively attained in particularly when a well-established background in Da Vinci® X Surgical System utilization is achieved.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/8822068","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141973725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short- and Midterm Outcomes of Off- and On-Pump Coronary Artery Bypass in Patients with a Mean Age of 65 or More: Systematic Review and Meta-Analysis 平均年龄为 65 岁或以上的患者使用非泵和泵上冠状动脉搭桥术的短期和中期疗效:系统回顾和元分析
IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-09 DOI: 10.1155/2024/3616580
Jake E. Trotman, Toluwalase F. Eboka, Neil A. Smart, Nicola King

Background. Advancing age is a nonmodifiable risk factor for the development of coronary artery disease. Furthermore, patients >65 years old are considered at high risk for coronary artery bypass grafting (CABG). The aim of this study was to investigate whether there were any differences in clinical outcomes for patients with a mean age ≥65 undergoing CABG on or off pump. Methods. Systematic searches were conducted in EMBASE, PubMed, Web of Science, and Cochrane Central Registry of Controlled Trials (CENTRAL). The key search terms used were “cardiopulmonary bypass” OR “On pump” AND “off pump” OR “beating heart” AND “coronary artery bypass grafting” OR “CABG” AND “age.” This was followed by a meta-analysis assessing the primary outcomes mortality, myocardial infarction, renal failure, and stroke in the short—(30 days) and midterm (12–44 months) and repeat revascularisation at midterm follow up. Secondary outcomes investigated included postoperative atrial fibrillation, number of units of blood transfused, ventilation time, length of intensive care unit stay, and length of hospital stay. Results. 14 studies involving 10,260 participants, 5,141 of whom had on-pump CABG and 5,119 of whom had off-pump CABG were identified. There was a significantly greater need for repeat revascularisation in the off-pump group (risk ratio 1.47, 95% confidence interval 1.07 to 2.01, I2 = 0%, p = 0.02) at midterm follow up. The off-pump group also had a shorter hospital stay. All other comparisons were insignificant. Conclusion. A number of different factors contribute to whether the increased need for repeat revascularisation for off-pump patients is truly clinically significant. This requires further investigation in meta-analysis based on longer-term trials in patients with a mean age ≥65. Otherwise, the similarity in clinical outcomes for patients in this age group suggests the choice to carry out CABG on or off pump should continue to be at the surgeon’s discretion.

背景。年龄增长是冠状动脉疾病发病的一个不可改变的危险因素。此外,65 岁的患者被认为是冠状动脉旁路移植术(CABG)的高风险人群。本研究旨在探讨平均年龄≥65岁的患者在使用或不使用泵的情况下接受冠状动脉旁路移植术的临床结果是否存在差异。研究方法。在 EMBASE、PubMed、Web of Science 和 Cochrane 对照试验中央登记处 (CENTRAL) 中进行了系统检索。使用的关键检索词为 "心肺旁路术 "或 "开泵 "和 "关泵 "或 "心脏跳动 "和 "冠状动脉旁路移植术 "或 "CABG "和 "年龄"。随后进行了一项荟萃分析,评估了短期(30 天)和中期(12-44 个月)的死亡率、心肌梗死、肾功能衰竭和中风的主要结果,以及中期随访时重复血管再通的情况。次要研究结果包括术后心房颤动、输血单位数、通气时间、重症监护室住院时间和住院时间。研究结果14 项研究共涉及 10,260 名参与者,其中 5,141 人接受了体外循环心脏搭桥术,5,119 人接受了体外循环心脏搭桥术。在中期随访中,非泵组需要重复血管再通的比例明显更高(风险比 1.47,95% 置信区间 1.07 至 2.01,I2 = 0%,P = 0.02)。非泵组的住院时间也更短。所有其他比较结果均不显著。结论非泵患者重复血管重建需求的增加是否具有真正的临床意义,有许多不同的因素。这需要在对平均年龄≥65岁的患者进行的长期试验基础上进行的荟萃分析中进一步研究。否则,该年龄组患者临床结果的相似性表明,选择在泵上还是在泵下进行 CABG 应继续由外科医生决定。
{"title":"Short- and Midterm Outcomes of Off- and On-Pump Coronary Artery Bypass in Patients with a Mean Age of 65 or More: Systematic Review and Meta-Analysis","authors":"Jake E. Trotman,&nbsp;Toluwalase F. Eboka,&nbsp;Neil A. Smart,&nbsp;Nicola King","doi":"10.1155/2024/3616580","DOIUrl":"https://doi.org/10.1155/2024/3616580","url":null,"abstract":"<div>\u0000 <p><i>Background</i>. Advancing age is a nonmodifiable risk factor for the development of coronary artery disease. Furthermore, patients &gt;65 years old are considered at high risk for coronary artery bypass grafting (CABG). The aim of this study was to investigate whether there were any differences in clinical outcomes for patients with a mean age ≥65 undergoing CABG on or off pump. <i>Methods</i>. Systematic searches were conducted in EMBASE, PubMed, Web of Science, and Cochrane Central Registry of Controlled Trials (CENTRAL). The key search terms used were “cardiopulmonary bypass” OR “On pump” AND “off pump” OR “beating heart” AND “coronary artery bypass grafting” OR “CABG” AND “age.” This was followed by a meta-analysis assessing the primary outcomes mortality, myocardial infarction, renal failure, and stroke in the short—(30 days) and midterm (12–44 months) and repeat revascularisation at midterm follow up. Secondary outcomes investigated included postoperative atrial fibrillation, number of units of blood transfused, ventilation time, length of intensive care unit stay, and length of hospital stay. <i>Results</i>. 14 studies involving 10,260 participants, 5,141 of whom had on-pump CABG and 5,119 of whom had off-pump CABG were identified. There was a significantly greater need for repeat revascularisation in the off-pump group (risk ratio 1.47, 95% confidence interval 1.07 to 2.01, <i>I</i><sup>2</sup> = 0%, <i>p</i> = 0.02) at midterm follow up. The off-pump group also had a shorter hospital stay. All other comparisons were insignificant. <i>Conclusion</i>. A number of different factors contribute to whether the increased need for repeat revascularisation for off-pump patients is truly clinically significant. This requires further investigation in meta-analysis based on longer-term trials in patients with a mean age ≥65. Otherwise, the similarity in clinical outcomes for patients in this age group suggests the choice to carry out CABG on or off pump should continue to be at the surgeon’s discretion.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/3616580","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141967782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Donor Coronary Artery Disease on Recipient Outcomes in Heart Transplantation 供体冠状动脉疾病对心脏移植受体预后的影响
IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-09 DOI: 10.1155/2024/4957703
Aakash Shah, Justin Robinson, Corbin E. Goerlich, Chetan Pasrija, Bartley P. Griffith

Background. Efforts to expand the heart donor pool have included the use of extended criteria donors (e.g., advanced age or comorbid conditions). Another potential avenue is donor hearts with pre-existing coronary artery disease (CAD). Methods. A retrospective cohort study was performed using the Organ Procurement and Transplantation Network database between 10/1/1987 and 12/3/2020. Postoperative complications, graft failure, and survival were examined between recipients of donor hearts with abnormal (CAD donor) versus normal (non-CAD donor) coronary angiogram. Analysis was performed in unmatched cohorts as well as after propensity score matching. Results. A total of 12,230 heart transplant recipients were identified, of which 940 (7.6%) had an abnormal donor coronary angiogram. There were no differences between CAD and non-CAD donor groups in acute rejection, stroke, or dialysis prior to discharge or treatment for rejection <1 year. However, the CAD donor group had a greater pacemaker incidence (5.2% vs. 3.6%, P = 0.02). After matching, 785 patients were in each group and there were no differences in perioperative outcomes or treatment for rejection <1 year. There was no difference in 10-year freedom from graft failure (53.1% vs. 54.6%, log rank = 1.03, and P = 0.31) or cumulative survival (54.7% vs. 55.8%, log rank = 0.63, and P = 0.43) between the matched CAD and non-CAD donor groups. Conclusion. The presence of CAD may not be a contraindication to transplantation. Carefully selected donor hearts with CAD may have equivalent postoperative and long-term outcomes to donor hearts without CAD. Further study in this area may expand the pool of donors.

背景。扩大心脏供体库的努力包括使用扩展标准供体(如高龄或合并症)。另一个潜在的途径是捐献预先存在冠状动脉疾病(CAD)的心脏。方法。利用器官获取和移植网络数据库对 1987 年 10 月 1 日至 2020 年 3 月 12 日期间的情况进行了回顾性队列研究。对冠状动脉造影异常(CAD 供体)与冠状动脉造影正常(非 CAD 供体)的供体心脏受体之间的术后并发症、移植失败和存活率进行了研究。分析在非匹配队列和倾向得分匹配后进行。结果。共确定了 12,230 名心脏移植受者,其中 940 人(7.6%)的供体冠状动脉造影异常。在急性排斥反应、中风、出院前透析或排斥反应治疗<1年方面,CAD和非CAD供体组之间没有差异。不过,CAD供体组的起搏器安装率更高(5.2% vs. 3.6%,P = 0.02)。配对后,两组各有785名患者,围手术期结果或排斥反应治疗<1年无差异。匹配的 CAD 供体组和非 CAD 供体组在 10 年免于移植失败(53.1% 对 54.6%,对数秩 = 1.03,P = 0.31)或累积存活率(54.7% 对 55.8%,对数秩 = 0.63,P = 0.43)方面没有差异。结论存在 CAD 可能不是移植的禁忌症。精心挑选的有 CAD 的供体心脏可能与无 CAD 的供体心脏具有相同的术后和长期预后。这方面的进一步研究可能会扩大供体库。
{"title":"Impact of Donor Coronary Artery Disease on Recipient Outcomes in Heart Transplantation","authors":"Aakash Shah,&nbsp;Justin Robinson,&nbsp;Corbin E. Goerlich,&nbsp;Chetan Pasrija,&nbsp;Bartley P. Griffith","doi":"10.1155/2024/4957703","DOIUrl":"https://doi.org/10.1155/2024/4957703","url":null,"abstract":"<div>\u0000 <p><i>Background</i>. Efforts to expand the heart donor pool have included the use of extended criteria donors (e.g., advanced age or comorbid conditions). Another potential avenue is donor hearts with pre-existing coronary artery disease (CAD). <i>Methods</i>. A retrospective cohort study was performed using the Organ Procurement and Transplantation Network database between 10/1/1987 and 12/3/2020. Postoperative complications, graft failure, and survival were examined between recipients of donor hearts with abnormal (CAD donor) versus normal (non-CAD donor) coronary angiogram. Analysis was performed in unmatched cohorts as well as after propensity score matching. <i>Results</i>. A total of 12,230 heart transplant recipients were identified, of which 940 (7.6%) had an abnormal donor coronary angiogram. There were no differences between CAD and non-CAD donor groups in acute rejection, stroke, or dialysis prior to discharge or treatment for rejection &lt;1 year. However, the CAD donor group had a greater pacemaker incidence (5.2% vs. 3.6%, <i>P</i> = 0.02). After matching, 785 patients were in each group and there were no differences in perioperative outcomes or treatment for rejection &lt;1 year. There was no difference in 10-year freedom from graft failure (53.1% vs. 54.6%, log rank = 1.03, and <i>P</i> = 0.31) or cumulative survival (54.7% vs. 55.8%, log rank = 0.63, and <i>P</i> = 0.43) between the matched CAD and non-CAD donor groups. <i>Conclusion</i>. The presence of CAD may not be a contraindication to transplantation. Carefully selected donor hearts with CAD may have equivalent postoperative and long-term outcomes to donor hearts without CAD. Further study in this area may expand the pool of donors.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/4957703","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141967781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Branch-First Technique of Aortic Arch Replacement: A Systematic Review and Meta-Analysis 主动脉弓置换的分支先行技术:系统回顾和元分析
IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-02 DOI: 10.1155/2024/1869656
Lubna Bakr, Tharushi Wijesena, Ravi De Silva, Jason M. Ali

Objectives. Aortic arch replacement is a major surgical intervention. This meta-analysis aims to combine the international literature on the branch-first technique to describe its outcomes and offer a comparison to the standard techniques. Methods. PubMed and Cochrane were searched for studies on the branch-first technique in aortic arch surgery including those comparing this technique with the conventional ones. Mortality, neurological complications, bleeding, and renal replacement therapy were the major endpoints of interest. Subgroup analysis was performed for both single- and double-armed studies. Odds ratios with 95% confidence interval were used as summary estimates. The random-effects model was used for all outcomes. Results. Ten studies from three countries with a total of 498 patients were included. Proportional analysis of the branch-first technique estimated mortality of (3%, 95% CI [0.02–0.05]), neurological complications of (8%, 95% CI [0.03–0.13]), re-exploration for bleeding of (9%, 95% CI [0.05–0.13]), and renal replacement therapy of (9%, 95% CI [0.05–0.12]). This meta-analysis revealed no significant differences between the branch-first technique and the conventional technique in mortality (5% vs. 15%, OR = 0.32, 95% CI [0.08–1.18], p = 0.09, I2 = 40%), neurological complications (10% vs. 16%, OR = 0.53, 95% CI [0.24–1.21], p = 0.13, I2 = 0%), or renal replacement therapy (12% vs. 14%, OR = 0.72, 95% CI [0.33–1.59], p = 0.41, I2 = 0%). Conclusions. Branch-first technique provides a promising alternative approach in aortic arch surgery with no different surgical risks and potentially reduced operative complexity. Randomised controlled trials are needed to further investigate the safety and advantages of this technique.

目的。主动脉弓置换术是一项重要的外科干预手术。本荟萃分析旨在综合有关分支先行技术的国际文献,描述其结果并与标准技术进行比较。方法。在 PubMed 和 Cochrane 上搜索有关主动脉弓手术中分支先行技术的研究,包括将该技术与传统技术进行比较的研究。死亡率、神经系统并发症、出血和肾脏替代治疗是研究的主要终点。对单臂和双臂研究进行了分组分析。使用带有 95% 置信区间的比值比作为汇总估计值。所有结果均采用随机效应模型。研究结果来自三个国家的十项研究共纳入了 498 名患者。分支先行技术的比例分析估计死亡率为(3%,95% CI [0.02-0.05]),神经系统并发症为(8%,95% CI [0.03-0.13]),因出血而再次手术为(9%,95% CI [0.05-0.13]),肾脏替代治疗为(9%,95% CI [0.05-0.12])。这项荟萃分析显示,分支先行技术与传统技术在死亡率方面没有显著差异(5% vs. 15%,OR = 0.32,95% CI [0.08-1.18],P = 0.09,I2 = 40%)、神经系统并发症(10% vs. 16%,OR = 0.53,95% CI [0.24-1.21],p = 0.13,I2 = 0%)或肾脏替代治疗(12% vs. 14%,OR = 0.72,95% CI [0.33-1.59],p = 0.41,I2 = 0%)方面无显著差异。结论分支先行技术为主动脉弓手术提供了一种很有前景的替代方法,手术风险无差别,并有可能降低手术复杂性。需要进行随机对照试验来进一步研究该技术的安全性和优势。
{"title":"Branch-First Technique of Aortic Arch Replacement: A Systematic Review and Meta-Analysis","authors":"Lubna Bakr,&nbsp;Tharushi Wijesena,&nbsp;Ravi De Silva,&nbsp;Jason M. Ali","doi":"10.1155/2024/1869656","DOIUrl":"https://doi.org/10.1155/2024/1869656","url":null,"abstract":"<div>\u0000 <p><i>Objectives</i>. Aortic arch replacement is a major surgical intervention. This meta-analysis aims to combine the international literature on the branch-first technique to describe its outcomes and offer a comparison to the standard techniques. <i>Methods</i>. PubMed and Cochrane were searched for studies on the branch-first technique in aortic arch surgery including those comparing this technique with the conventional ones. Mortality, neurological complications, bleeding, and renal replacement therapy were the major endpoints of interest. Subgroup analysis was performed for both single- and double-armed studies. Odds ratios with 95% confidence interval were used as summary estimates. The random-effects model was used for all outcomes. <i>Results</i>. Ten studies from three countries with a total of 498 patients were included. Proportional analysis of the branch-first technique estimated mortality of (3%, 95% CI [0.02–0.05]), neurological complications of (8%, 95% CI [0.03–0.13]), re-exploration for bleeding of (9%, 95% CI [0.05–0.13]), and renal replacement therapy of (9%, 95% CI [0.05–0.12]). This meta-analysis revealed no significant differences between the branch-first technique and the conventional technique in mortality (5% vs. 15%, OR = 0.32, 95% CI [0.08–1.18], <i>p</i> = 0.09, <i>I</i>2 = 40%), neurological complications (10% vs. 16%, OR = 0.53, 95% CI [0.24–1.21], <i>p</i> = 0.13, <i>I</i>2 = 0%), or renal replacement therapy (12% vs. 14%, OR = 0.72, 95% CI [0.33–1.59], <i>p</i> = 0.41, <i>I</i>2 = 0%). <i>Conclusions</i>. Branch-first technique provides a promising alternative approach in aortic arch surgery with no different surgical risks and potentially reduced operative complexity. Randomised controlled trials are needed to further investigate the safety and advantages of this technique.</p>\u0000 </div>","PeriodicalId":15367,"journal":{"name":"Journal of Cardiac Surgery","volume":"2024 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/1869656","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Cardiac Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1